Timing matters: study probes catheter use before prostate surgery

NCT ID NCT07603011

Recruiting now Knowledge-focused Sponsor: Eskişehir Osmangazi University Medicine Faculty Hospital Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study looks at men with urinary retention who need a catheter before having prostate laser surgery (HoLEP, ThuLEP, or ThuFLEP). Researchers want to see if the length of time with a catheter affects how well the surgery works. They will measure changes in urinary symptoms, flow rate, and leftover urine. The goal is to find the best timing for surgery to improve recovery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Laser enucleation of the prostate (HoLEP, ThuLEP, or ThuFLEP)
What this could lead to: If successful, this study could help doctors determine the best timing for prostate laser surgery in men who need a catheter, potentially improving recovery and urinary function.
What could go wrong: This is an observational study with only 54 participants, so results may not apply to everyone. It looks at past data, not a controlled experiment, so it cannot prove cause and effect.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BENIGN PROSTATE OBSTRUCTION (BPO) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

benign prostatic hyperplasia bladder neck obstruction Lower Urinary Tract Symptoms Urinary Retention

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BENIGN PROSTATE OBSTRUCTION (BPO) URINARY RETENTION

Contacts and locations

Locations

Eskisehir Osmangazi University, Faculty of Medicine, Department of Urology
RECRUITING

Eskişehir, Eskişehir, 26040, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.